Considering the role of cytotoxic CD4+ T cells in tumor surveillance, we suggest that suppression of senescent CD4+ T cells may contribute to the increased cancer risk in RA patients under permissive conditions [28, 29]. The gene discussed is CD4; the disease is cancer.